AquaGen
Helene Velle Mayer currently serves as a Driftsoperatør at AquaGen since January 2024. Prior experience includes a role as a Researcher in Fish Health at Cermaq Global from August 2021 to January 2024 and as a Driftstekniker at Mowi ASA from July 2017 to August 2020. Helene obtained a Master's degree in Fish Health/Aquamedicine from the University of Bergen between 2018 and 2021 and holds a Bachelor of Science in Marine Biology and Aquaculture from the Norwegian University of Science and Technology, completed in 2017.
This person is not in any teams
AquaGen
1 followers
Aqua Gen is a selective breeding company which develops, produces and delivers genetic material to the global sea-farming industry. Through a market-oriented research and development Aqua Gen has achieved a leading position as a provider of fertilized eggs of Atlantic salmon and rainbow trout. Aqua Gen owns and preserves the world’s most refined genetic material from Atlantic salmon and rainbow trout. Since the 1970’s when collection of these fish species began, a continual research and development program has been carried on in cooperation with commercial operators and research institutions. By focusing on genetic traits related to health, animal welfare, growth and quality, Aqua Gen contributes an important component of a sustainable and profitable aquaculture industry. Aqua Gen carries out R and D projects both independently and in cooperation with a large number of national and international research institutions. The goal of R and D work is to generate and implement new research findings and technology in existing breeding and health work. Aqua Gen’s family-based selective breeding covers a unique and desirable material for research on Norwegian farmed salmon, and is thereby a national resource which benefits the aquaculture industry in many areas. Aqua Gen’s vision: The independent and leading provider of innovative genetic and biological products to the global aquaculture industry.